Edgewise Therapeutics Inc (EWTX)
17.37
-0.14
(-0.80%)
USD |
NASDAQ |
Jun 17, 16:00
17.36
-0.01
(-0.06%)
After-Hours: 20:00
Edgewise Therapeutics Free Cash Flow: -99.39M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -99.39M |
| December 31, 2023 | -97.69M |
| September 30, 2023 | -85.85M |
| June 30, 2023 | -76.63M |
| March 31, 2023 | -72.43M |
| December 31, 2022 | -58.18M |
| September 30, 2022 | -52.53M |
| Date | Value |
|---|---|
| June 30, 2022 | -47.95M |
| March 31, 2022 | -41.00M |
| December 31, 2021 | -34.18M |
| September 30, 2021 | -29.32M |
| June 30, 2021 | -23.88M |
| March 31, 2021 | -18.21M |
| December 31, 2020 | -14.84M |
Free Cash Flow Range, Past 5 Years
-99.39M
Minimum
Mar 2024
-14.84M
Maximum
Dec 2020
-53.72M
Average
-50.24M
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 5.106B |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Catalyst Pharmaceuticals Inc | 81.59M |
| Cytokinetics Inc | -421.55M |
| Amicus Therapeutics Inc | -88.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.60M |
| Cash from Investing (Quarterly) | -268.31M |
| Cash from Financing (Quarterly) | 241.07M |
| Free Cash Flow Per Share (Quarterly) | -0.33 |
| Free Cash Flow Yield | -8.20% |